# Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-niraparib-in-patients-aged-65-years-and-older-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Giorgio Valabrega,Bhavana Pothuri,Ana Oaknin,Whitney S. Graybill,Ana Beatriz Sánchez,Colleen McCormick,Jean‐François Baurain,Anna V. Tinker,Hannelore Denys,Roisin E. O’Cearbhaill,Sakari Hietanen,Richard G. Moore,Anja Ør Knudsen,Thibault de La Motte Rouge,Florian Heitz,Tally Levy,Whitney York,Divya Gupta,Bradley J. Monk,Antonio González-Martı́n |
| Citations | 7 |
| DOI | 10.1016/j.ygyno.2024.03.009 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.gynecologiconcology-online.net/article/S0090-8258(24)00154-9/pdf |
| OpenAlex ID | https://openalex.org/W4399316087 |
| PMID | 38833992 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Jean‐François Baurain](https://scholariq.org/researchers/jean-francois-baurain/)
- [Roisin E. O’Cearbhaill](https://scholariq.org/researchers/roisin-e-o-cearbhaill/)
- [Hannelore Denys](https://scholariq.org/researchers/hannelore-denys/)
- [Florian Heitz](https://scholariq.org/researchers/florian-heitz/)
- [Antonio González-Martı́n](https://scholariq.org/researchers/antonio-gonzalez-mart-n/)

## Paper funders

Showing 8 of 20.

- [Amgen](https://scholariq.org/funders/amgen/)
- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)
- [Pfizer](https://scholariq.org/funders/pfizer/)
- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [GlaxoSmithKline](https://scholariq.org/funders/glaxosmithkline/)
- [Sanofi](https://scholariq.org/funders/sanofi/)
- [Gilead Sciences](https://scholariq.org/funders/gilead-sciences/)
- [Teva Pharmaceutical Industries](https://scholariq.org/funders/teva-pharmaceutical-industries/)

## Paper journal

- [Gynecologic Oncology](https://scholariq.org/journals/gynecologic-oncology/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.